Seriously? As if we can afford the continuation
of the share buyback! We would then have to
borrow. As KP says what do we use as collateral.
The products particularly Nextellis obviously require
sales representatives to ensure sales. It just cannot
be good enough to increase market penetration
without this personal representation. As Mikyc noted
adds $100m to marketing o/heads. This is not
sustainable and makes the initial acquisition look
a bit iffy. I mean it has a value but absolutely nothing
like the numbers SR negotiated with Fornieri .
One a convicted criminal the other either very
dumb or possibly very smart.
- Forums
- ASX - By Stock
- What MYX chart shouts
MYX
mayne pharma group limited
Add to My Watchlist
1.53%
!
$5.30

Seriously? As if we can afford the continuation of the share...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.30 |
Change
0.080(1.53%) |
Mkt cap ! $426.5M |
Open | High | Low | Value | Volume |
$5.29 | $5.33 | $5.15 | $94.90K | 18.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 218 | $5.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.33 | 769 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 584 | 5.300 |
7 | 2005 | 5.290 |
3 | 1078 | 5.280 |
2 | 636 | 5.270 |
2 | 1952 | 5.260 |
Price($) | Vol. | No. |
---|---|---|
5.330 | 851 | 4 |
5.340 | 5150 | 2 |
5.350 | 20748 | 4 |
5.360 | 551 | 3 |
5.370 | 125 | 1 |
Last trade - 12.35pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online